1. Home
  2. REVB vs RAYA Comparison

REVB vs RAYA Comparison

Compare REVB & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$1.15

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$4.96

Market Cap

4.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
RAYA
Founded
2020
2019
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.3M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
REVB
RAYA
Price
$1.15
$4.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
107.2K
30.1K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,101,325.00
Revenue This Year
N/A
$20.95
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.78
52 Week Low
$0.83
$3.13
52 Week High
$60.48
$736.99

Technical Indicators

Market Signals
Indicator
REVB
RAYA
Relative Strength Index (RSI) 63.48 59.36
Support Level $1.03 $3.70
Resistance Level $1.00 $5.62
Average True Range (ATR) 0.08 0.46
MACD 0.04 0.18
Stochastic Oscillator 93.03 72.33

Price Performance

Historical Comparison
REVB
RAYA

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: